Efficacy and tolerability of lasmiditan, an oral 5-HT(1 F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study - Farkkila, M; Diener, HC; Geraud, G (The Lancet Neurology, 2012)